Search

Now showing items 21-30 of 355

Traumatic dislocation of the atlanto-occipital joint

Govender S.; Vlok G.J.; Fisher-Jeffes N.; Du Preez C.P. (2003)

We present four patients who had sustained a traumatic dislocation of the atlanto-occipital joint. The diagnosis was initially missed in two patients. One patient, who was neurologically intact, was treated non-operatively. ...

Childhood drug-resistant tuberculosis in the Western Cape Province of South Africa

Schaaf H.S.; Marais B.J.; Hesseling A.C.; Gie R.P.; Beyers N.; Donald P.R. (2006)

Aim: Continued surveillance of drug resistance amongst children presenting with culture-confirmed tuberculosis to a tertiary care hospital and to community clinics. Methods: Drug susceptibility testing for isoniazid and ...

Impact of unfortified human milk feeding on weight gain and mineral status of very-low-birth-weight infants after discharge from a kangaroo mother care unit

Kirsten G.; Van Zyl J.; Kirsten C.; Thompson E. (2004)

[No abstract available]

Nosocomial transmission of Mycobacterium tuberculosis in kangaroo mother care units: A risk in tuberculosis-endemic areas

Heyns L.; Gie R.P.; Goussard P.; Beyers N.; Warren R.M.; Marais B.J. (2006)

Background and aim: Kangaroo mother care (KMC) has become the standard of care for low-risk preterm babies born in developing countries. However, the potential risk of nosocomial transmission of Mycobacterium tuberculosis ...

Prioritising prevention strategies for patients in antiretroviral treatment programmes in resource-limited settings

Spaar A.; Graber C.; Dabis F.; Coutsoudis A.; Bachmann L.; McIntyre J.; Schechter M.; Prozesky H.W.; Tuboi S.; Dickinson D.; Kumarasamy N.; Pujdades-Rodriquez M.; Sprinz E.; Schilthuis H.J.; Cahn P.; Low N.; Egger M. (2010)

Expanded access to antiretroviral therapy (ART) offers opportunities to strengthen HIV prevention in resource-limited settings. We invited 27 ART programmes from urban settings in Africa, Asia and South America to participate ...

Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007

Cornell M.; Grimsrud A.; Fairall L.; Fox M.P.; Van Cutsem G.; Giddy J.; Wood R.; Prozesky H.; Mohapi L.; Graber C.; Egger M.; Boulle A.; Myer L. (2010)

Objective: Little is known about the temporal impact of the rapid scale-up of large antiretroviral therapy (ART) services on programme outcomes. We describe patient outcomes [mortality, loss-to-follow-up (LTFU) and retention] ...

HIV risk exposure among South African children in public health facilities

Shisana O.; Connolly C.; Rehle T.M.; Mehtar S.; Dana P. (2008)

The study investigates the risk exposure to HIV infection among South African children aged 2-9 years served by public health services. Together with their biological mothers, 3471 children and were recruited from inpatient ...

Change in co-receptor usage of current South African HIV-1 subtype C primary isolates

Van Rensburg E.J.; Smith T.-L.; Zeier M.; Robson B.; Sampson C.; Treurnicht F.; Engelbrecht S. (2002)

Phenotypic analysis was performed on 13 HIV-1 strains isolated between 2000 and 2001. Syncytium-inducing and non-syncytium-inducing subtype C viruses were found, most of which used more than one co-receptor. For the first ...

Phase II trial of ZD0473 as second-line therapy in mesothelioma

Giaccone G.; O'Brien M.E.R.; Byrne M.J.; Bard M.; Kaukel E.; Smit B. (2002)

A phase II, open-label, non-comparative, multicentre trial of the platinum analogue ZD0473 as second-line therapy for pleural mesothelioma has been completed. The objectives were to evaluate the activity and tolerability ...

Esomeprazole 40 mg administered intravenously has similar safety and efficacy profiles to the oral formulation in patients with erosive esophagitis

Schneider, H.; Van Rensburg, C.; Schmidt, S.; Aboo, N.; Makela, H.; Naucler, E.; Hallerback, B.; Svedberg, L-E. (2004)

Background/Aims: An intravenous formulation of esomeprazole has been developed for use in patients where oral administration is not appropriate. This study evaluated safety after 1 and 4 weeks, and efficacy after 4 weeks' ...

1
2
3
4
5
6
. . .
36